Bicycle Therapeutics plc American Depositary Shares
Symbol: BCYC (NASDAQ)
8.30
▼ (-0.42%) -0.035
Company Description:
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
Key Stats
- Today's Open: $8.43
- Today's High: $8.645
- Today's Low: $8.211
- Today's Volume: 163.85K
- Yesterday Close: $8.33
- Yesterday High: $8.39
- Yesterday Low: $7.61
- Yesterday Volume: 480.52K
- Last Min Volume: 640
- Last Min High: $8.304
- Last Min Low: $8.291
- Last Min VWAP: $8.29916
Company Profile
- Name: Bicycle Therapeutics plc American Depositary Shares
- Website: https://www.bicycletherapeutics.com
- Listed Date: 2019-05-23
- Location: CAMBRIDGE, X0
- Market Status: Active
- CIK Number: 0001761612
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $577.32M
- Round Lot: 100
- Outstanding Shares: 69.31M
- Asset Type: ADRC
RECENT FILINGS FOR BCYC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 3 | View |
| 2025-09-10 | 3 | View |
| 2025-09-08 | 8-K | View |
| 2025-08-14 | EFFECT | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 3 | View |
| 2025-08-14 | 424B3 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | CORRESP | View |
| 2025-08-12 | UPLOAD | View |
| 2025-08-08 | S-3 | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-08 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |